Smooth muscle myosin heavy chain (SM-MHC) is a contractile protein that is selectively expressed in differentiated smooth muscle cells and myoepithelial cells. Immunohistochemical detection of SM-MHC provides high specificity for smooth muscle differentiation and therefore assists pathologists in distinguishing true smooth muscle tumors from histologic mimics. In breast pathology, SM-MHC is regarded as a reliable myoepithelial marker, particularly useful when evaluating complex proliferative or sclerosing lesions in which the presence or absence of a myoepithelial cell layer determines the diagnosis.

In gynecological pathology, SM-MHC is a valuable adjunct in the evaluation of uterine mesenchymal tumors. It contributes to the distinction between leiomyomas, leiomyosarcomas, endometrial stromal tumors, and other spindle cell neoplasms when used in combination with complementary smooth muscle markers.

Clinical Utility in Breast Pathology

• Identification of intact myoepithelial cell layers surrounding ducts and lobules in benign and in situ breast lesions
• Support for exclusion of stromal invasion in cases of ductal carcinoma in situ, sclerosing adenosis, and radial scar
• Ancillary marker in challenging cases where conventional myoepithelial markers show equivocal staining

Clinical Utility in Gynecological Pathology

• Confirmation of smooth muscle differentiation in uterine smooth muscle tumors, including leiomyoma, cellular leiomyoma, and leiomyosarcoma
• Assistance in differentiating smooth muscle tumors from endometrial stromal neoplasms and other mesenchymal lesions
• Useful component of immunohistochemical panels applied to gynecologic spindle cell tumors.

Key Features of Anti-Smooth Muscle Myosin Antibodies

• High specificity for smooth muscle myosin heavy chain isoforms expressed in differentiated smooth muscle cells
• Strong cytoplasmic staining pattern that is easy to interpret in appropriately preserved FFPE tissues
• Suitable for use in standardized immunohistochemistry protocols on automated staining platforms
• Available in CE/IVD format with manufacturer-validated instructions for diagnostic laboratories
• Optimal performance when used as part of a multiparametric antibody panel including desmin, h-caldesmon, smooth muscle actin, and calponin

It should be noted that occasional non-specific staining has been reported in endothelial cells and certain stromal components. For this reason, interpretation of SM-MHC staining must always be performed in conjunction with histomorphology and additional immunohistochemical markers.